ARTICLE | Distillery Therapeutics
DLK identified as target for Fragile X syndrome
September 19, 2019 2:32 AM UTC
INDICATION: Fragile X syndrome
Inhibiting DLK, a mediator of neuronal injury responses, could treat Fragile X syndrome. In fruit flies with the disease, systemic DLK knockout or a tool compound DLK inhibitor prevented repetitive grooming behaviors in adults and reduced neurodevelopmental defects by preventing synaptic overgrowth at the larval neuromuscular junction. Next steps include testing DLK inhibition in a mouse model of Fragile X...
BCIQ Company Profiles
BCIQ Target Profiles